Back to Journals » OncoTargets and Therapy
OncoTargets and Therapy
ISSN: 1178-6930
OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (6473)
- Volume 17, 2024 (35)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Latest articles:
- 5 records -
A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report
Zhou D, Ying J, Hu S, Li J, Liu H
OncoTargets and Therapy 2024, 17:261-265
Published Date: 27 March 2024
M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases
Feng Y, Qiao S, Chen J, Wen X, Chen Y, Song X, Xu J, Qiao X, Yang J, Zhang S, Feng Y, Gao Y
OncoTargets and Therapy 2024, 17:243-260
Published Date: 26 March 2024
Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin
Liu W, Huang X, Luo W, Liu X, Chen W
OncoTargets and Therapy 2024, 17:227-242
Published Date: 22 March 2024
Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
Hou Y, Yan J, Shi K, Liu X, Gao F, Wu T, Meng P, Zhang M, Jiang Y, Wang X
OncoTargets and Therapy 2024, 17:215-226
Published Date: 23 March 2024
Apolipoprotein E is a Potential Biomarker for Predicting Cancer Prognosis and is Correlated with Immune Infiltration
Chen J, Zhu H, Chen S, Mi H
OncoTargets and Therapy 2024, 17:199-214
Published Date: 19 March 2024